Younger patients with type 2 diabetes need better glycaemic control: Results of a community-based study describing factors associated with a high HbA1c value

British Journal of General Practice

Volumn 53, Issue 490, 2003, Pages 389-391

  Rothenbacher, Dietrich ^a   Rüter, Gernot ^b   Saam, Stefan ^a   Brenner, Hermann ^a  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b NONE

Author keywords

HbA1c; Observational study; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL OBSERVATION; COMMUNITY CARE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVENTION AND CONTROL; RISK; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 0037509848     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Nathan DM, Singer DE, Hurtxhal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984; 320: 341-346.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Diabetes Care 1998; 21: 1414-1431.
3. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 1999; 22: S27-S31.
4. Herman WH, Aubert RE, Engelgau MM, et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998; 15: 1045-1051.
5. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS41). BMJ 2000; 320: 1373-1378.